Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Depo-Medrone 120mg/3ml suspension for injection vials (Pfizer Ltd) |
| BNF code | 1001022K0BBAEAE |
| Virtual Medicinal Product | Methylprednisolone acetate 120mg/3ml suspension for injection vials |
| Name | Depo-Medrone 120mg/3ml suspension for injection vials |
| Date of name applicability | 7 Jun 2004 |
| Previous name | Depo-Medrone 40mg/ml injection 3ml vials |
| Supplier | Pfizer Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Intraarticular |
| Licensed Route | |
| Licenced route | Intrabursal |
| Licensed Route | |
| Licenced route | Periarticular |
| Licensed Route | |
| Licenced route | Intramuscular |
| Licensed Route | |
| Licenced route | Intralesional |
| Actual Medicinal Product Packs | |
| Depo-Medrone 120mg/3ml suspension for injection vials (Pfizer Ltd) 10 vial | |
| Depo-Medrone 120mg/3ml suspension for injection vials (Pfizer Ltd) 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_5.0.0_20240506000001, imported on 6th May 2024 at 05:05:44.